Opko Health Inc (OPK)

[tomsylver]

OPKO HEALTH LONG-TERM THESIS INTACT DESPITE SELLOFF, SAYS BARRINGTON

TheFly.com
9/28/2015
Barrington Research

OPKO Health analyst commentary
OPKO Health long-term thesis intact despite selloff, says Barrington. Barrington analyst Tareq Affouri says the long-term thesis for OPKO Health remains intact despite the 55% pullback in shares from the June high. He lowered his price target for the stock to $19 from $20 and keeps an Outperform rating on the name.